PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 18, 2026Clinical Interventions in Aging0 citationsOpen Access

Transcutaneous Auricular Vagus Nerve Stimulation and Pectoral-Intercostal Fascial Block for the Prevention of Chronic Postsurgical Pain in Elderly Patients Undergoing Off-Pump Coronary Artery Bypass Grafting: A 2×2 Factorial, Double-Blinded, Randomized Clinical Trial

SCSichen CuiLYLuguang YanPHPeiying Huang

Key Points

  • This trial aims to evaluate the effectiveness of transcutaneous auricular vagus nerve stimulation (taVNS) and pectoral-intercostal fascial block (PIFB) in preventing chronic postsurgical pain (CPSP) in elderly patients post-cardiac surgery.
  • Conducted a 2×2 factorial randomized clinical trial design.
  • Included 260 elderly patients aged 60 and above undergoing off-pump coronary artery bypass grafting (OPCABG).
  • Compared four treatment groups: taVNS with PIFB, taVNS with placebo, sham taVNS with PIFB, and sham taVNS with placebo.
  • Analyzed outcomes including CPSP incidence at 3 months and acute pain relief using logistic regression and mediation analyses.
  • CPSP prevalence was 34.6%, with taVNS significantly reducing CPSP incidence compared to sham (28.6% vs 40.9%, P = 0.036).
  • PIFB did not show a significant reduction in overall CPSP incidence (30.2% vs 38.8%, P = 0.143), but alleviated acute pain on postoperative day 1.
  • Risk factors for CPSP identified included preoperative anxiety and high IL-6 levels, among others.

Abstract

Background: Chronic postsurgical pain (CPSP) is common after off-pump coronary artery bypass grafting (OPCABG) in elderly patients. This trial investigated the efficacy of perioperative transcutaneous auricular vagus nerve stimulation (taVNS) and pectoral-intercostal fascial block (PIFB) for CPSP prevention. Methods: In this 2× 2 factorial trial, 260 elderly patients (≥ 60 years) undergoing OPCABG were randomized to taVNS + ropivacaine PIFB, taVNS + placebo PIFB, sham taVNS + ropivacaine PIFB, or sham taVNS + placebo PIFB groups. The primary outcome was CPSP incidence at 3 months postoperatively. Several secondary outcomes were evaluated. Logistic regression was employed to analyze risk factors associated with CPSP. Lastly, mediation analyses were performed to explore the mediating factors between interventions and CPSP. Results: The overall incidence of CPSP was 34.6%. No interaction was found between taVNS and PIFB. Compared with sham taVNS, taVNS significantly reduced CPSP incidence (28.6% vs 40.9%, P = 0.036), alleviated acute pain and improved recovery quality. PIFB did not reduce overall CPSP incidence (30.2% vs 38.8%, P = 0.143), though it alleviated acute pain on postoperative day 1 and reduced moderate-to-severe CPSP. Risk factors for CPSP included preoperative anxiety, pain catastrophizing, acute postoperative pain, and high IL-6 levels. Mediation analysis indicated taVNS’s benefits were partially mediated by reducing acute pain (19.3%) and IL-6 (20.4%). Conclusion: Perioperative taVNS significantly reduced CPSP incidence and enhanced postoperative recovery in elderly OPCABG patients, partly mediated by alleviating acute pain and inflammation. Single-shot PIFB showed limited preventive effect on overall CPSP. Keywords: postoperative pain, vagus nerve stimulation, nerve block, aged, randomized controlled trial

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Cui et al. (2026) studied this question.

synapsesocial.com/papers/69e3211640886becb65403cehttps://doi.org/10.2147/cia.s583971
Ask AI
Helpful
Bookmark
Share
View Full Paper